TherapeuticsMD, Inc. (TXMD)

TherapeuticsMD Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	9.19	7.48	5.06	4.33	38.07	64.91
Cash & Short-Term Investments	9.19	7.48	5.06	4.33	38.07	64.91
Cash Growth	51.41%	47.91%	16.92%	-88.63%	-41.35%	-19.36%
Accounts Receivable	3.39	3.53	3.56	3.09	-	-
Other Receivables	0.68	0.67	0.54	-	-	-
Receivables	4.08	4.2	4.1	3.09	-	-
Prepaid Expenses	0.15	0.09	0.07	0.25	1.17	2.73
Restricted Cash	-	-	-	-	11.25	-
Other Current Assets	2.71	2.68	3.03	4.13	4.87	51.83
Total Current Assets	16.12	14.45	12.26	11.8	55.35	119.47
Property, Plant & Equipment	4.83	5.29	6.1	6.87	7.66	9.06
Other Intangible Assets	3.56	3.76	4.32	6.1	6.94	7.14
Long-Term Accounts Receivable	12.63	13.71	16.01	18.48	20.25	-
Other Long-Term Assets	0.4	0.44	0.13	0.06	0.25	33.8
Total Assets	37.53	37.66	38.82	43.31	90.46	169.47

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.46	0.38	0.26	0.03	2.16	3.37
Accrued Expenses	0.84	0.77	0.49	1.66	12.76	9.12
Current Portion of Long-Term Debt	-	-	-	-	-	188.27
Current Portion of Leases	1.04	0.98	1.63	1.47	1.39	1.36
Other Current Liabilities	2.67	2.67	2.78	3.69	30.53	50.77
Total Current Liabilities	5	4.79	5.17	6.85	46.84	252.89
Long-Term Leases	4.52	5.12	5.54	6.53	7.37	8.06
Other Long-Term Liabilities	0.87	0.87	0.74	0.64	1.11	2.14
Total Liabilities	10.4	10.78	11.45	14.02	55.32	263.09

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	979.26	979.26	979.18	978.92	974.5	957.73
Retained Earnings	-952.14	-952.39	-951.82	-949.64	-939.36	-1,051
Shareholders' Equity	27.13	26.88	27.37	29.29	35.14	-93.62
Total Liabilities & Equity	37.53	37.66	38.82	43.31	90.46	169.47

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	5.56	6.1	7.18	8.01	8.76	197.69
Net Cash (Debt)	3.63	1.39	-2.12	-3.68	29.31	-132.79
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	0.31	0.12	-0.18	-0.35	3.13	-16.68
Filing Date Shares Outstanding	11.57	11.57	11.57	11.53	9.95	8.67
Total Common Shares Outstanding	11.57	11.57	11.53	11.53	9.5	8.6
Working Capital	11.12	9.66	7.09	4.94	8.51	-133.42
Book Value Per Share	2.34	2.32	2.37	2.54	3.70	-10.89
Tangible Book Value	23.57	23.12	23.05	23.19	28.2	-100.77
Tangible Book Value Per Share	2.04	2.00	2.00	2.01	2.97	-11.72
Machinery	-	-	-	-	2.1	2.34
Leasehold Improvements	-	-	-	-	0.05	0.08

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: May 12, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 27, 2026

Data Sources Report a data error